Lithium and the monoamine neurotransmitters in the rat hippocampus.
D000109:Acetylcholine / Q000494:pharmacology; D000200:Action Potentials / Q000187:drug effects*; D000613:Aminobutyrates / Q000494:pharmacology*; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D004347:Drug Interactions; D004558:Electric Stimulation; D004569:Electroencephalography; D006624:Hippocampus / Q000187:drug effects* / Q000502:physiology; D007478:Iontophoresis; D008094:Lithium / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects; D009433:Neural Inhibition / Q000187:drug effects; D009434:Neural Pathways; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011149:Pons / Q000502:physiology; D051381:Rats; D012701:Serotonin / Q000494:pharmacology*; D012702:Serotonin Antagonists; D013268:Stimulation, Chemical
D000613:Aminobutyrates; D012702:Serotonin Antagonists; D012701:Serotonin; D008094:Lithium; D000109:Acetylcholine; D009638:Norepinephrine